Keyphrases
Diffuse Large B-cell Lymphoma (DLBCL)
100%
Overexpression
73%
MRNA Destabilization
66%
Hematopoietic Stem Cells
66%
Cancer Cell Survival
66%
R-CHOP
66%
Effective Selection
66%
Lymphomagenesis
66%
Specific Lipids
66%
Metabolic Profiling
66%
Colorectal Cancer Cells
66%
Tumor Suppressor
66%
PR Domain
66%
Airway Inflammatory
66%
Matrix-assisted Laser Desorption Ionization Mass Spectrometry Imaging
66%
Oncogene
66%
In Vivo Imaging
66%
Lipid Profile
66%
Induced Apoptosis
46%
Proliferation Apoptosis
33%
Binding Site
33%
Mechanistic Insight
33%
Non-germinal Centre
33%
Drug-resistant Tumor
33%
Inhibits Proliferation
33%
Diffuse Large B-cell Lymphoma Cells
33%
Functional Screening
33%
Overall Survival
33%
Family Members
33%
Cell-like
33%
Transcription Start Site
33%
Transcriptional Regulator
33%
Genetic Mapping
33%
Knock-in Mouse Model
33%
Transcriptome Sequencing
33%
In Cancer
33%
Mouse Model
33%
Screening Approach
33%
Long Non-coding RNA (LncRNA)
20%
PRDM16
16%
Megakaryocytes
16%
Colony Forming Units
16%
Medicine and Dentistry
Diffuse Large B-Cell Lymphoma
66%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
66%
Mass Spectrometry Imaging
66%
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
66%
Hematopoietic Cell
66%
Neoplasm
33%
Diseases
22%
Megakaryocyte
16%
Immunology and Microbiology
Mouse Mutant
66%
Inflammation Response
66%
Hematopoietic Cell
66%
Airway
66%
Megakaryocyte
16%
